Strati, Paolo <br/><br/>
Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.  [electronic resource] 

 -  Cancer  Feb 2014 
 - 452 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.28442  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Female<br/>Humans<br/>Immune Tolerance--drug effects<br/>Immunotherapy--adverse effects<br/>Leukemia, Lymphocytic, Chronic, B-Cell--therapy<br/>Male<br/>Pancytopenia--chemically induced